ASX - By Stock
|
LTP |
Re:
IPO - LTR Pharma Ltd - 11 December 2023 #
|
|
Lefevre
|
137 |
47K |
7 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
137
|
47K
|
7
|
|
ASX - By Stock
|
CC9 |
Re:
[INTERVIEW] Chariot Corporation (ASX:CC9) confirms LCT pegmatites at Black Mountain
|
|
Lefevre
|
2 |
572 |
0 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
2
|
572
|
0
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
183 |
59K |
6 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
183
|
59K
|
6
|
|
ASX - By Stock
|
LTP |
Re:
Ann: LTP Secures Global CoDevelopment Agreement with Aptar Pharma
|
|
Lefevre
|
75 |
28K |
6 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
75
|
28K
|
6
|
|
ASX - By Stock
|
LTP |
Re:
Ann: LTP Secures Global CoDevelopment Agreement with Aptar Pharma
|
|
Lefevre
|
75 |
28K |
10 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
75
|
28K
|
10
|
|
ASX - By Stock
|
LTP |
Re:
ED Game Changer
|
|
Lefevre
|
26 |
9.4K |
6 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
26
|
9.4K
|
6
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
183 |
59K |
7 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
183
|
59K
|
7
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
183 |
59K |
4 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
183
|
59K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Revenue update ?
|
|
Lefevre
|
3 |
1.3K |
2 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
3
|
1.3K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
183 |
59K |
0 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
183
|
59K
|
0
|
|
ASX - By Stock
|
C29 |
Re:
Ann: Licence Application Granted around Ulytau Uranium Project
|
|
Lefevre
|
16 |
3.4K |
2 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
16
|
3.4K
|
2
|
|
ASX - By Stock
|
CYC |
Revenue update ?
|
|
Lefevre
|
3 |
1.3K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3
|
1.3K
|
3
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
Lefevre
|
2.0K |
1.4M |
5 |
31/07/24 |
31/07/24 |
IPOs
|
2.0K
|
1.4M
|
5
|
|
ASX - By Stock
|
CC9 |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Lefevre
|
1 |
1.8K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
1
|
1.8K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
12 |
3.8K |
22 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
12
|
3.8K
|
22
|
|
ASX - By Stock
|
ENL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
7 |
1.6K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
7
|
1.6K
|
1
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.1K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
23
|
7.1K
|
0
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
10 |
3.3K |
5 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
10
|
3.3K
|
5
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
10 |
3.3K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
10
|
3.3K
|
4
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Lefevre
|
708 |
574K |
0 |
29/07/24 |
29/07/24 |
IPOs
|
708
|
574K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
19 |
6.4K |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
19
|
6.4K
|
2
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
Lefevre
|
2.0K |
1.4M |
5 |
25/07/24 |
25/07/24 |
IPOs
|
2.0K
|
1.4M
|
5
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL Receives Firm Commitments to Raise $10.5 Million
|
|
Lefevre
|
67 |
18K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
67
|
18K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
Lefevre
|
33 |
10K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
33
|
10K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL Receives Firm Commitments to Raise $10.5 Million
|
|
Lefevre
|
67 |
18K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
67
|
18K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
In search of growth: Pharma deals target precommercial biotech assets
|
|
Lefevre
|
21 |
6.0K |
7 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21
|
6.0K
|
7
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Lefevre
|
67 |
14K |
6 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
67
|
14K
|
6
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.1K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
23
|
7.1K
|
1
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.1K |
0 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
23
|
7.1K
|
0
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Updated Investor Presentation
|
|
Lefevre
|
3 |
1.3K |
3 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
3
|
1.3K
|
3
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Lefevre
|
67 |
14K |
14 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
14K
|
14
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Lefevre
|
67 |
14K |
7 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
14K
|
7
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
Lefevre
|
185 |
66K |
4 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
185
|
66K
|
4
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.1K |
2 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
23
|
7.1K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Notice of initial substantial holder from IFL
|
|
Lefevre
|
10 |
4.0K |
12 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
10
|
4.0K
|
12
|
|
ASX - By Stock
|
BDX |
Re:
BDX Media and Publications
|
|
Lefevre
|
40 |
8.8K |
3 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
40
|
8.8K
|
3
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
183 |
59K |
18 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
183
|
59K
|
18
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
183 |
59K |
9 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
183
|
59K
|
9
|
|
ASX - By Stock
|
LTP |
Re:
IT WORKS!
|
|
Lefevre
|
23 |
11K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
23
|
11K
|
2
|
|
ASX - By Stock
|
BDX |
Re:
BDX Media and Publications
|
|
Lefevre
|
40 |
8.8K |
0 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
40
|
8.8K
|
0
|
|
ASX - By Stock
|
MAP |
Re:
Ann: Completion of Autoimmune Program with Ginkgo Bioworks
|
|
Lefevre
|
9 |
3.1K |
1 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
9
|
3.1K
|
1
|
|
ASX - By Stock
|
MAP |
Re:
Ann: Completion of Autoimmune Program with Ginkgo Bioworks
|
|
Lefevre
|
9 |
3.1K |
1 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
9
|
3.1K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
$100M Market Cap
|
|
Lefevre
|
19 |
9.3K |
13 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
19
|
9.3K
|
13
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm completes oversubscribed Share Purchase Plan
|
|
Lefevre
|
9 |
4.4K |
1 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
9
|
4.4K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
$100M Market Cap
|
|
Lefevre
|
19 |
9.3K |
1 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
19
|
9.3K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Change in substantial holding
|
|
Lefevre
|
16 |
5.0K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
16
|
5.0K
|
6
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
Lefevre
|
2.0K |
1.4M |
10 |
18/06/24 |
18/06/24 |
IPOs
|
2.0K
|
1.4M
|
10
|
|
ASX - By Stock
|
AGN |
Re:
$100M Market Cap
|
|
Lefevre
|
19 |
9.3K |
15 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
19
|
9.3K
|
15
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Change of Director's Interest Notice
|
|
Lefevre
|
18 |
3.4K |
4 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
18
|
3.4K
|
4
|
|
ASX - By Stock
|
CLG |
Re:
Ann: Business Update
|
|
Lefevre
|
60 |
27K |
17 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
60
|
27K
|
17
|
|